Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitusCONRAD, Susan C; MCGRATH, Maureen T; GITELMAN, Stephen E et al.The Journal of pediatrics. 2002, Vol 140, Num 2, pp 235-240, issn 0022-3476Article

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitusHEROLD, Kevan C; HAGOPIAN, William; BLUESTONE, Jeffrey A et al.The New England journal of medicine. 2002, Vol 346, Num 22, pp 1692-1698, issn 0028-4793Article

Relation of body fat indexes to vitamin D status and deficiency among obese adolescentsLENDERS, Carine M; FELDMAN, Henry A; KLISH, William J et al.The American journal of clinical nutrition. 2009, Vol 90, Num 3, pp 459-467, issn 0002-9165, 9 p.Article

Recommendations for the Definition of Clinical Responder in Insulin Preservation StudiesBEAM, Craig A; GITELMAN, Stephen E; PALMER, Jerry P et al.Diabetes (New York, NY). 2014, Vol 63, Num 9, pp 3120-3127, issn 0012-1797, 8 p.Article

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Lancet (British edition). 2011, Vol 378, Num 9789, pp 412-419, issn 0140-6736, 8 p.Article

Nephrogenic syndrome of inappropriate antidiuresisFELDMAN, Brian J; ROSENTHAL, Stephen M; GITELMAN, Stephen E et al.The New England journal of medicine. 2005, Vol 352, Num 18, pp 1884-1890, issn 0028-4793, 7 p.Article

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsPESCOVITZ, Mark D; GREENBAUM, Carla J; RODRIGUEZ, Henry et al.Diabetes care. 2014, Vol 37, Num 2, pp 453-459, issn 0149-5992, 7 p.Article

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of RespondersHEROLD, Kevan C; GITELMAN, Stephen E; SAYRE, Peter H et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3766-3774, issn 0012-1797, 9 p.Article

Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in childrenHUANG, Erica; FELDMAN, Bran J; SCHWARTZ, David et al.The Journal of pediatrics. 2006, Vol 148, Num 1, pp 128-131, issn 0022-3476, 4 p.Article

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of TreatmentORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Diabetes care. 2014, Vol 37, Num 4, pp 1069-1075, issn 0149-5992, 7 p.Article

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialWHERRETT, Diane K; BUNDY, Brian; MONZAVI, Roshanak et al.Lancet (British edition). 2011, Vol 378, Num 9788, pp 319-327, issn 0140-6736, 9 p.Article

Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes : Results of a blinded controlled studySEYFERT-MARGOLIS, Vicki; GISLER, Trang D; NEPOM, Gerald T et al.Diabetes (New York, NY). 2006, Vol 55, Num 9, pp 2588-2594, issn 0012-1797, 7 p.Article

Nephrogenic syndrome of inappropriate antidiuresis : A novel disorder in water balance in pediatric patientsGITELMAN, Stephen E; FELDMAN, Brian J; ROSENTHAL, Stephen M et al.The American journal of medicine. 2006, Vol 119, Num 7A, issn 0002-9343, S54-S58Conference Paper

Increased incidence in post-transplant diabetes mellitus in children: a case-control analysisGREENSPAN, Louise C; GITELMAN, Stephen E; LEUNG, Mary Ann et al.Pediatric nephrology (Berlin, West). 2002, Vol 17, Num 1, pp 1-5, issn 0931-041XArticle

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsMORAN, Antoinette; BUNDY, Brian; SANDA, Srinath et al.Lancet (British edition). 2013, Vol 381, Num 9881, pp 1905-1915, issn 0140-6736, 11 p.Article

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet DataGREENBAUM, Carla J; BEAM, Craig A; KRAUSE-STEINRAUF, Heidi et al.Diabetes (New York, NY). 2012, Vol 61, Num 8, pp 2066-2073, issn 0012-1797, 8 p.Article

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell FunctionPESCOVITZ, Mark D; GREENBAUM, Carla J; RASKIN, Philip et al.The New England journal of medicine. 2009, Vol 361, Num 22, pp 2143-2152, issn 0028-4793, 10 p.Article

A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetesHEROLD, Kevan C; GITELMAN, Stephen E; MASHARANI, Umesh et al.Diabetes (New York, NY). 2005, Vol 54, Num 6, pp 1763-1769, issn 0012-1797, 7 p.Article